These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 27447662

  • 1. Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses.
    Martínez-Sobrido L, de la Torre JC.
    Viruses; 2016 Jul 20; 8(7):. PubMed ID: 27447662
    [Abstract] [Full Text] [Related]

  • 2. Reverse Genetics Approaches to Control Arenavirus.
    Martínez-Sobrido L, Cheng BY, de la Torre JC.
    Methods Mol Biol; 2016 Jul 20; 1403():313-51. PubMed ID: 27076139
    [Abstract] [Full Text] [Related]

  • 3. Development of Recombinant Arenavirus-Based Vaccines.
    Martínez-Sobrido L, de la Torre JC.
    Methods Mol Biol; 2017 Jul 20; 1581():133-149. PubMed ID: 28374247
    [Abstract] [Full Text] [Related]

  • 4. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L, de la Torre JC.
    Expert Rev Vaccines; 2016 Sep 20; 15(9):1113-21. PubMed ID: 27118328
    [Abstract] [Full Text] [Related]

  • 5. Lassa Virus Reverse Genetics.
    Martínez-Sobrido L, Paessler S, de la Torre JC.
    Methods Mol Biol; 2017 Sep 20; 1602():185-204. PubMed ID: 28508222
    [Abstract] [Full Text] [Related]

  • 6. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Jul 20; 89(14):7373-84. PubMed ID: 25972555
    [Abstract] [Full Text] [Related]

  • 7. Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.
    Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.
    J Vis Exp; 2013 Aug 01; (78):. PubMed ID: 23928556
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasmid-Based Lassa Virus Reverse Genetics.
    Martínez-Sobrido L, Ye C, de la Torre JC.
    Methods Mol Biol; 2024 Aug 01; 2733():115-131. PubMed ID: 38064030
    [Abstract] [Full Text] [Related]

  • 10. Generation of Bi-Reporter-Expressing Tri-Segmented Arenavirus.
    Ye C, Martinez-Sobrido L.
    Methods Mol Biol; 2022 Aug 01; 2524():223-233. PubMed ID: 35821475
    [Abstract] [Full Text] [Related]

  • 11. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Apr 01; 89(7):3523-33. PubMed ID: 25589652
    [Abstract] [Full Text] [Related]

  • 12. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.
    Capul AA, de la Torre JC.
    Virology; 2008 Dec 05; 382(1):107-14. PubMed ID: 18929379
    [Abstract] [Full Text] [Related]

  • 13. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC.
    Ann N Y Acad Sci; 2009 Sep 05; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [Abstract] [Full Text] [Related]

  • 14. Arenavirus reverse genetics for vaccine development.
    Ortiz-Riaño E, Cheng BYH, Carlos de la Torre J, Martínez-Sobrido L.
    J Gen Virol; 2013 Jun 05; 94(Pt 6):1175-1188. PubMed ID: 23364194
    [Abstract] [Full Text] [Related]

  • 15. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
    Iwasaki M, Cubitt B, Sullivan BM, de la Torre JC.
    J Virol; 2016 Jan 06; 90(6):3187-97. PubMed ID: 26739049
    [Abstract] [Full Text] [Related]

  • 16. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
    Ye C, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2020 Sep 15; 94(19):. PubMed ID: 32669332
    [Abstract] [Full Text] [Related]

  • 17. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies.
    Emonet SE, Urata S, de la Torre JC.
    Virology; 2011 Mar 15; 411(2):416-25. PubMed ID: 21324503
    [Abstract] [Full Text] [Related]

  • 18. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A, Martin V, Moreno H, de la Torre JC.
    Curr Top Microbiol Immunol; 2016 Mar 15; 392():231-76. PubMed ID: 26472215
    [Abstract] [Full Text] [Related]

  • 19. Replication-Competent Influenza A Viruses Expressing Reporter Genes.
    Breen M, Nogales A, Baker SF, Martínez-Sobrido L.
    Viruses; 2016 Jun 23; 8(7):. PubMed ID: 27347991
    [Abstract] [Full Text] [Related]

  • 20. Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.
    Cheng BYH, Nogales A, de la Torre JC, Martínez-Sobrido L.
    Virology; 2017 Jan 15; 501():35-46. PubMed ID: 27855284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.